Retrospective Cohort Study on the Incidence and Management of Hemiplegic Shoulder Pain in Stroke Inpatients.
TL;DR
A retrospective analysis of subacute stroke inpatients who developed PHS during rehabilitation at a single center revealed a significant prevalence of PHS among stroke inpatients, consistent with existing literature.
OpenAlex 토픽 ·
Stroke Rehabilitation and Recovery
Botulinum Toxin and Related Neurological Disorders
Cerebral Palsy and Movement Disorders
A retrospective analysis of subacute stroke inpatients who developed PHS during rehabilitation at a single center revealed a significant prevalence of PHS among stroke inpatients, consistent with exis
- 연구 설계 cohort study
APA
Igor Santos Neto, Miguel Guimarães, et al. (2024). Retrospective Cohort Study on the Incidence and Management of Hemiplegic Shoulder Pain in Stroke Inpatients.. Cureus, 16(12), e76030. https://doi.org/10.7759/cureus.76030
MLA
Igor Santos Neto, et al.. "Retrospective Cohort Study on the Incidence and Management of Hemiplegic Shoulder Pain in Stroke Inpatients.." Cureus, vol. 16, no. 12, 2024, pp. e76030.
PMID
39835068
Abstract
[BACKGROUND] Painful hemiplegic shoulder (PHS) is a prevalent and challenging complication following a stroke and can significantly impair a patient's engagement in rehabilitation, leading to poorer functional outcomes and extended hospital stays. This retrospective cohort study aims to investigate the incidence, etiology, and management of PHS in stroke inpatients, focusing on the effectiveness of various therapeutic interventions.
[METHODS] We conducted a retrospective analysis of subacute stroke inpatients who developed PHS during rehabilitation at a single center. Medical records were reviewed to assess the incidence of PHS, underlying causes, and treatment modalities. Primary outcome measures included the prevalence of PHS, the distribution of identified etiologies, and therapeutic outcomes associated with different management strategies.
[RESULTS] Our findings revealed a significant prevalence of PHS among stroke inpatients, consistent with existing literature. The multifactorial etiology included spasticity, adhesive capsulitis, glenohumeral subluxation, central post-stroke pain, and complex regional pain syndrome, with advanced age, low functional scores, motor and sensory impairments, and comorbidities such as diabetes mellitus identified as key risk factors. Management strategies ranged from conservative approaches, such as physical modalities and slings, to advanced interventions, including intra-articular corticosteroid injections, botulinum toxin type A applications, nerve blocks, and radiofrequency neuromodulation. Corticosteroid injections and electrical stimulation were particularly effective in alleviating pain and improving functional outcomes. Notably, pulsed radiofrequency modulation targeting the suprascapular and axillary nerves showed superior efficacy in enhancing the passive range of motion compared to conventional nerve blocks, although the effectiveness of botulinum toxin type A was inconsistent.
[CONCLUSIONS] This study emphasizes the multifaceted nature of PHS in stroke inpatients, underlining the importance of individualized and comprehensive treatment strategies. While several therapeutic interventions, particularly corticosteroid injections and pulsed radiofrequency, demonstrated effectiveness, the variability in treatment outcomes highlights the need for further investigation. Future research should focus on larger patient cohorts with extended follow-up periods to better elucidate the progression of PHS and refine management approaches. Despite limitations, including the retrospective study design and a short follow-up period, these findings provide valuable insights into the prevalence, progression, and treatment of PHS in stroke rehabilitation.
[METHODS] We conducted a retrospective analysis of subacute stroke inpatients who developed PHS during rehabilitation at a single center. Medical records were reviewed to assess the incidence of PHS, underlying causes, and treatment modalities. Primary outcome measures included the prevalence of PHS, the distribution of identified etiologies, and therapeutic outcomes associated with different management strategies.
[RESULTS] Our findings revealed a significant prevalence of PHS among stroke inpatients, consistent with existing literature. The multifactorial etiology included spasticity, adhesive capsulitis, glenohumeral subluxation, central post-stroke pain, and complex regional pain syndrome, with advanced age, low functional scores, motor and sensory impairments, and comorbidities such as diabetes mellitus identified as key risk factors. Management strategies ranged from conservative approaches, such as physical modalities and slings, to advanced interventions, including intra-articular corticosteroid injections, botulinum toxin type A applications, nerve blocks, and radiofrequency neuromodulation. Corticosteroid injections and electrical stimulation were particularly effective in alleviating pain and improving functional outcomes. Notably, pulsed radiofrequency modulation targeting the suprascapular and axillary nerves showed superior efficacy in enhancing the passive range of motion compared to conventional nerve blocks, although the effectiveness of botulinum toxin type A was inconsistent.
[CONCLUSIONS] This study emphasizes the multifaceted nature of PHS in stroke inpatients, underlining the importance of individualized and comprehensive treatment strategies. While several therapeutic interventions, particularly corticosteroid injections and pulsed radiofrequency, demonstrated effectiveness, the variability in treatment outcomes highlights the need for further investigation. Future research should focus on larger patient cohorts with extended follow-up periods to better elucidate the progression of PHS and refine management approaches. Despite limitations, including the retrospective study design and a short follow-up period, these findings provide valuable insights into the prevalence, progression, and treatment of PHS in stroke rehabilitation.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 2 | |
| 해부 | suprascapular
|
scispacy | 1 | ||
| 해부 | intra-articular corticosteroid
|
scispacy | 1 | ||
| 약물 | [BACKGROUND] Painful hemiplegic shoulder
|
scispacy | 1 | ||
| 약물 | Corticosteroid
|
scispacy | 1 | ||
| 질환 | Hemiplegic Shoulder Pain
|
scispacy | 1 | ||
| 질환 | Stroke
|
C0038454
Cerebrovascular accident
|
scispacy | 1 | |
| 질환 | hemiplegic
|
C0259928
hemiplegics
|
scispacy | 1 | |
| 질환 | spasticity
|
C0026838
Muscle Spasticity
|
scispacy | 1 | |
| 질환 | capsulitis
|
C0263907
Capsulitis
|
scispacy | 1 | |
| 질환 | glenohumeral subluxation
|
scispacy | 1 | ||
| 질환 | motor and sensory impairments
|
scispacy | 1 | ||
| 질환 | diabetes mellitus
|
C0011849
Diabetes Mellitus
|
scispacy | 1 | |
| 질환 | pain
|
C0030193
Pain
|
scispacy | 1 | |
| 질환 | PHS
→ Painful hemiplegic shoulder
|
scispacy | 1 | ||
| 기타 | axillary nerves
|
scispacy | 1 | ||
| 기타 | botulinum toxin type
|
scispacy | 1 | ||
| 기타 | Inpatients
|
scispacy | 1 | ||
| 기타 | PHS
→ Painful hemiplegic shoulder
|
scispacy | 1 | ||
| 기타 | botulinum toxin type A
|
scispacy | 1 |
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.